Clinical Trial Update: Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing repeat doses of ferumoxytol with iron sucrose in CKD patients with iron deficiency anemia on hemodialysis; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Iron Deficiency Anemia

Drugs mentioned

• FERUMOXYTOL (ferumoxytol)
• Iron sucrose (iron sucrose)

Snippet

Sponsor: AMAG Pharmaceuticals, Inc. | Conditions: Iron Deficiency Anemia Treatment, Chronic Kidney Disease(CKD) | Phase 4 | Status: COMPLETED | Results posted: 2019-07-19